Journal articleSci Adv · July 22, 2022
Featured Publication
Subunit vaccines inducing antibodies against tumor-specific antigens have yet to be clinically successful. Here, we use a supramolecular α-helical peptide nanofiber approach to design epitope-specific vaccines raising simultaneous B cell, CD8+ T cell, and ...
Full textLink to itemCite
Journal articleSci Rep · July 14, 2021
Featured Publication
A major challenge in developing an effective vaccine against HIV-1 is the genetic diversity of its viral envelope. Because of the broad range of sequences exhibited by HIV-1 strains, protective antibodies must be able to bind and neutralize a widely mutate ...
Full textLink to itemCite
Journal articleBiomaterials · June 2021
Featured Publication
Biomaterials capable of inducing immune responses with minimal associated inflammation are of interest in applications ranging from tissue repair to vaccines. Here we report the design of self-assembling randomized polypeptide nanomaterials inspired by gla ...
Full textCite
Journal articleNature nanotechnology · April 2021
Featured Publication
Despite the overwhelming success of vaccines in preventing infectious diseases, there remain numerous globally devastating diseases without fully protective vaccines, particularly human immunodeficiency virus (HIV), malaria and tuberculosis. Nanotechnology ...
Full textCite
Journal articleProceedings of the National Academy of Sciences of the United States of America · April 2021
Featured Publication
Complement protein C3dg, a key linkage between innate and adaptive immunity, is capable of stimulating both humoral and cell-mediated immune responses, leading to considerable interest in its use as a molecular adjuvant. However, the potential of C3dg as a ...
Full textCite
Journal articleAdvanced healthcare materials · March 2021
Featured Publication
Widespread vaccination is essential to global health. Significant barriers exist to improving vaccine coverage in lower- and middle-income countries, including the costly requirements for cold-chain distribution and trained medical personnel to administer ...
Full textCite
Journal articleAdvanced materials (Deerfield Beach, Fla.) · October 2020
Featured Publication
Peptide nanofibers are useful for many biological applications, including immunotherapy, tissue engineering, and drug delivery. The robust lengthwise assembly of these peptides into nanofibers is typically difficult to control, resulting in polydisperse fi ...
Full textCite
Journal articleBiomater Sci · June 21, 2020
Featured Publication
Several different self-assembling peptide systems that form nanofibers have been investigated as vaccine platforms, but design principles for adjusting the character of the immune responses they raise have yet to be well articulated. Here we compared the i ...
Full textLink to itemCite
Journal articleBiomaterials · May 2020
Featured Publication
Short peptides are poorly immunogenic when delivered sublingually - under the tongue. Nanomaterial delivery of peptides could be utilized to improve immunogenicity towards designed sublingual vaccines, but nanomaterials have not been widely successful in s ...
Full textCite
Journal articleFrontiers in immunology · January 2020
Featured Publication
Current treatments for chronic immune-mediated diseases such as psoriasis, rheumatoid arthritis, or Crohn's disease commonly rely on cytokine neutralization using monoclonal antibodies; however, such approaches have drawbacks. Frequent repeated dosing can ...
Full textCite
Journal articleJournal of controlled release : official journal of the Controlled Release Society · July 2018
Featured Publication
Influenza vaccines that can be administered intranasally or by other needle-free delivery routes have potential advantages over injected formulations in terms of patient compliance, cost, and ease of global distribution. Supramolecular peptide nanofibers h ...
Full textCite
Journal articleAdvanced healthcare materials · March 2018
Featured Publication
Supramolecular materials composed of proteins and peptides have been receiving considerable attention toward a range of diseases and conditions from vaccines to drug delivery. Owing to the relative newness of this class of materials, the bulk of work to da ...
Full textCite
Journal articleMedChemComm · January 2018
Featured Publication
Self-assembled peptide nanofibers raise significant antibody and T cell responses without adjuvants, but the mechanism by which they achieve this has not been fully elucidated. Myeloid differentiation primary response gene 88 (MyD88) previously has been sh ...
Full textCite
Journal articleMethods in molecular biology (Clifton, N.J.) · January 2018
Featured Publication
The design, formulation, and immunological evaluation of self-assembling peptide materials is relatively straightforward. Indeed, one of the advantages of synthetic self-assembling peptides is that one can progress from initial concept to in vivo testing i ...
Full textCite
Journal articleACS Biomater Sci Eng · December 11, 2017
Featured Publication
A supramolecular peptide vaccine system was designed in which epitope-bearing peptides self-assemble into elongated nanofibers composed almost entirely of alpha-helical structure. The nanofibers were readily internalized by antigen presenting cells and pro ...
Full textLink to itemCite
Journal articleBiomaterials · December 2017
Featured Publication
Active immunotherapies raising antibody responses against autologous targets are receiving increasing interest as alternatives to the administration of manufactured antibodies. The challenge in such an approach is generating protective and adjustable level ...
Full textCite
Journal articleAdvanced drug delivery reviews · May 2017
Featured Publication
Biomaterials employed to raise therapeutic immune responses have become a complex and active field. Historically, vaccines have been developed primarily to fight infectious diseases, but recent years have seen the development of immunologically active biom ...
Full textCite
Journal articleWiley interdisciplinary reviews. Nanomedicine and nanobiotechnology · March 2017
Featured Publication
Self-assembling coiled coils, which occur commonly in native proteins, have received significant interest for the design of new biomaterials-based medical therapies. Considerable effort over recent years has led to a detailed understanding of the self-asse ...
Full textCite
Journal articleACS nano · October 2016
Featured Publication
Biomaterials created from supramolecular peptides, proteins, and their derivatives have been receiving increasing interest for both immunological applications, such as vaccines and immunotherapies, as well as ostensibly nonimmunological applications, such ...
Full textCite
Journal articleJournal of biomedical materials research. Part A · August 2016
Featured Publication
Biomaterials used in the context of tissue engineering or wound repair are commonly designed to be "nonimmunogenic." However, previously it has been observed that self-assembled peptide nanofiber materials are noninflammatory despite their immunogenicity, ...
Full textCite
Journal articleActa biomaterialia · January 2016
Featured Publication
The majority of current vaccines depend on a continuous "cold chain" of storage and handling between 2 and 8°C. Vaccines experiencing temperature excursions outside this range can suffer from reduced potency. This thermal sensitivity results in significant ...
Full textCite
Journal articleCurrent opinion in immunology · August 2015
Featured Publication
Successful immunotherapies must be designed to elicit targeted immune responses having a specifiable phenotype across many dimensions, including the phenotypes of T cells, B cells, antigen-presenting cells, and others. For synthetic or subunit vaccines, st ...
Full textCite
Journal articleAdvanced healthcare materials · November 2014
Featured Publication
Epitope content plays a critical role in determining T-cell and antibody responses to vaccines, biomaterials, and protein therapeutics, but its effects are nonlinear and difficult to isolate. Here, molecular self-assembly is used to build a vaccine with pr ...
Full textCite
Journal articleNature materials · August 2014
Featured Publication
Biomaterials exhibiting precise ratios of different bioactive protein components are critical for applications ranging from vaccines to regenerative medicine, but their design is often hindered by limited choices and cross-reactivity of protein conjugation ...
Full textCite
Journal articleJournal of materials chemistry. B · May 2014
Featured Publication
Adaptive immune responses, characterized by T cells and B cells engaging and responding to specific antigens, can be raised by biomaterials containing proteins, peptides, and other biomolecules. How does one avoid, control, or exploit such responses? This ...
Full textCite
Journal articleBiomaterials · November 2013
Featured Publication
Balancing immunogenicity with inflammation is a central tenet of vaccine design, especially for subunit vaccines that utilize traditional pro-inflammatory adjuvants. Here we report that by using a nanoparticulate peptide-based vaccine, immunogenicity and l ...
Full textCite
Journal articleBiomaterials science · October 2013
Featured Publication
Self-assembled peptide materials have received considerable interest for a range of applications, including 3D cell culture, tissue engineering, and the delivery of cells and drugs. One challenge in applying such materials within these areas has been the e ...
Full textCite
Journal articleAdvanced healthcare materials · August 2013
Featured Publication
This work illustrates a strategy for the design of molecularly defined immunotherapies, using a blend of supramolecular peptide self-assembly and active site-directed protein capture. ...
Full textCite
Journal articleIntegrative biology : quantitative biosciences from nano to macro · March 2011
Featured Publication
Extracellular matrices (ECMs) are complex materials, containing at least dozens of different macromolecules that are assembled together, thus complicating their optimization towards applications in 3D cell culture or tissue engineering. The natural complex ...
Full textCite
Journal articleProceedings of the National Academy of Sciences of the United States of America · January 2010
Featured Publication
The development of vaccines and other immunotherapies has been complicated by heterogeneous antigen display and the use of incompletely defined immune adjuvants with complex mechanisms of action. We have observed strong antibody responses in mice without t ...
Full textCite